FDA Reviewers Guide Firms on Trial Design for Pediatric Cancer Drugs

Clinical Trials Advisor
Underscoring the importance of pediatric trial design, cancer experts recently guided drugmakers on whether their research plans for two investigational drugs could be feasibly used to combat some of the most life-threatening and hard-to-treat childhood cancers.

To View This Article:


Subscribe To Clinical Trials Advisor